ANAVEX LIFE SCIENCES CORP. (AVXL)
2025-06-30 | ||||
---|---|---|---|---|
Research and development | 9,959 | |||
General and administrative | 4,500 | |||
Total operating expenses | 14,459 | |||
Operating loss | -14,459 | |||
Interest income, net | 1,075 | |||
Foreign exchange gain (loss) | -11 | |||
Research and development incentive income | 127 | |||
Grant income | 25 | |||
Total other income, net | 1,216 | |||
Net loss and comprehensive loss | -13,243 | |||
Net loss per share, basic | -0.16 | |||
Net loss per share, diluted | -0.16 | |||
Weighted average number of shares outstanding, basic | 85,380,587 | |||
Weighted average number of shares outstanding, diluted | 85,380,587 |